Dicerna Pharmaceuticals reported $-16262000 in Pre-Tax Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acceleron Pharma XLRN:US $ -70.45M 6.94M
Alnylam Pharmaceuticals ALNY:US $ -212.93M 24.6M
Arrowhead Research ARWR:US $ -63.37M 33.45M
Biogen BIIB:US $ 814.2M 255M
Bluebird Bio BLUE:US $ -216.93M 14.49M
Dicerna Pharmaceuticals DRNA:US $ -16.26M 24.01M
Exelixis EXEL:US $ 53.26M 71.63M
Immunogen IMGN:US $ -37.34M 6.6M
Intercept Pharmaceuticals ICPT:US $ -3.63M 7.46M
Intrexon XON:US $ -29.88M 9.76M
IONIS PHARMACEUT IONS:US $ -84M 3M
Karyopharm Therapeutics KPTI:US $ -51706000 1.74M
Macrogenics MGNX:US $ -52.89M 12.95M
Mirati Therapeutics MRTX:US $ -76.76M 89.68M
Regeneron Pharmaceuticals REGN:US $ 1822.2M 2076.1M
Regulus Therapeutics RGLS:US $ -8.63M 2.6M
Ultragenyx Pharmaceutical RARE:US $ -72.82M 49.15M